TrimRx's Blog

10 min read

Survodutide for MASH: Why Glucagon Agonism Helps the Liver

Introduction Survodutide is one of the more interesting drugs in the fatty liver pipeline, and the reason comes down to a single design choice:…

10 min read

Survodutide Deep Dive: Liver-First Dual Agonist

Introduction Survodutide is a once-weekly glucagon and GLP-1 receptor dual agonist developed by Boehringer Ingelheim and Zealand Pharma, and its standout feature is a…

9 min read

Best Summer-Ready GLP-1 Programs: Expert Rankings

The best summer-ready GLP-1 programs share two traits: they start you fast, and they price honestly for the months the work actually takes.

9 min read

What Is the Strongest Healing Peptide?

BPC-157 has the strongest claim to the title of strongest healing peptide, and it is not particularly close in terms of research volume.

11 min read

Stress Eating After GLP-1: Rebuilding Coping Without Food

Stress eating doesn’t disappear during GLP-1 treatment; it goes quiet.

10 min read

Strength Coach’s Guide to GLP-1 Clients: Programming Notes

Coaching a client on a GLP-1 medication isn’t the same as coaching a typical fat-loss client, and treating it the same way costs them muscle.

14 min read

Strength Benchmarks to Hold While Losing 20 Percent Body Weight

Introduction While losing 20 percent of your body weight on a GLP-1, the benchmark that matters is this: your key lifts should finish within…

9 min read

STEP Targets That Predict Maintenance Success

Introduction Step targets predict weight maintenance success better than almost any other single habit metric, and the predictive range is specific: people who keep…

9 min read

State Pharmacy Boards and Peptides: Who Regulates What

Peptide regulation is split between two levels. The FDA decides, federally and uniformly, which peptides a compounding pharmacy may legally make.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.